Editors: Shigao Huang, Jie Yang

Current and Future Application of Artificial Intelligence in Clinical Medicine

eBook: US $44 Special Offer (PDF + Printed Copy): US $75
Printed Copy: US $53
Library License: US $176
ISBN: 978-1-68108-842-6 (Print)
ISBN: 978-1-68108-841-9 (Online)
Year of Publication: 2021
DOI: 10.2174/97816810884191210101


Current and Future Application of Artificial Intelligence in Clinical Medicine presents updates on the application of machine learning and deep learning techniques in medical procedures. . Chapters in the volume have been written by outstanding contributors from cancer and computer science institutes with the goal of providing updated knowledge to the reader. Topics covered in the book include 1) Artificial Intelligence (AI) applications in cancer diagnosis and therapy, 2) Updates in AI applications in the medical industry, 3) the use of AI in studying the COVID-19 pandemic in China, 4) AI applications in clinical oncology (including AI-based mining for pulmonary nodules and the use of AI in understanding specific carcinomas), 5) AI in medical imaging. Each chapter presents information on related sub topics in a reader friendly format. The combination of expert knowledge and multidisciplinary approaches highlighted in the book make it a valuable source of information for physicians and clinical researchers active in the field of cancer diagnosis and treatment (oncologists, oncologic surgeons, radiation oncologists, nuclear medicine physicians, and radiologists) and computer science scholars seeking to understand medical applications of artificial intelligence.


Artificial intelligence (AI) brought me a breakthrough regarding clinical data and computer models. Nowadays, with the development of AI significantly advances progress, we hope the researcher can utilize this modern technology to improve clinical accuracy such as diagnosis, prognosis, therapeutic, and so on. Clinical work is filled enough with patients and they need AI help to minimize workload and improve the high efficiency of the medical assignment.

Titled “Current and Prevalent Trends in Clinical Medicine with Artificial Intelligence” this book included AI application in cancer diagnosis and prognosis, AI accelerates the development and transformation of the medical care AI in China’s COVID-19 Pandemic and AI experience of fighting with the COVID-19. All readers welcome to read. In this book, you can learn the AI technology with Clinical knowledge., the latest advance of AI application in the clinic, even now, it can be applied in the COVID-19 pandemic. We are trying to collect the latest issue regarding AI in Clinical Oncology.

In preparing this book we have had the privilege of collaborating with outstanding contributors from leading comprehensive cancer and computer specialist. We believe that the authors’ expertise, distinguished pieces of knowledge, and multidisciplinary approaches provide a valuable source of information and can guide decision-making for physicians and clinical researchers.

All physicians active in the field of cancer diagnosis and treatment (oncologists, oncologic surgeons, radiation oncologists, nuclear medicine physicians, and radiologists) and computer specialists on artificial intelligence are the target audience for this book. The book can also be used to train young specialists who are preparing for a multidisciplinary crossover examination.

We dedicate this book to those who treat people with dignity and respect and to organizations and individuals committed to building a peaceful world.

Shigao Huang
Faculty of Health Science
University of Macau


Shaanxi Jiuzhou Biomedical Science and Technology Group referred to as “Jiuzhou Group”, founded in September 2006, is located in Xi'an Hi-tech Development Zone in China established by Shaanxi Jiuzhou Biotechnology Co., Ltd. and Shaanxi high tech Industry Investment Co., Ltd. Main business: research and development and transformation of cell biotechnology, professional platform service of life science, precision medical diagnosis, medical service, health management, etc. Jiuzhou Group began to invest in the construction of Shaanxi Jiuzhou biomedical science and Technology Park (currently, knew as Shaanxi Jiuzhou stem cell science and Technology Industrial Park) in 2002, which is a provincial key construction project in the 11th five year plan. At the beginning of the 12th Five Year Plan period, the first industrial transformation platform of cell gene was built in China (2010), and the whole industrial chain of cell collection, storage, detection, production and preparation, clinical research and application was built. After ten years of accumulation, the industrial pattern of "one park, one chain and one center" has been formed in Jiuzhou stem cell science and Technology Industrial Park, whole industrial chain of cell biology and Jiuzhou medical center.

Xi 'an Zer Huier Education Technology Co., Ltd., founded in 2018, in China, is a professional institution focusing on medical and health examination and training and improving the professional ability of the pharmaceutical industry. The company has the most professional team of teachers, all the lecturers are from domestic and foreign professional colleges and universities. They not only have made a lot of achievements in the relevant fields, but also have a wealth of teaching experience, focusing on the systematic training of professionals in the field of health care, to provide more breadth, validity, and professional training services for the field of health care in China.


.Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach.
.The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach.
.Cancer Medicine in an Ayurvedic Perspective: A Critical Overview.